HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Spiekerkoetter, E. Articles by Hoeper, M.M. Search for Related Content PubMed PubMed Citation Articles by Spiekerkoetter, E. Articles by Hoeper, M.M.

Effects of inhaled salbutamol in primary pulmonary hypertension

Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany

CORRESPONDENCE: E. Spiekerkoetter, Dept of Respiratory Medicine, Hannover Medical School, 30625, Hannover, Germany. Fax: 49 5115323353. E-mail: edda.spiekerkoetter@t-online.de

Keywords: peripheral airway obstruction, primary pulmonary hypertension, salbutamol

Received: December 12, 2001
Accepted April 12, 2002

Although lung function is grossly normal in patients with primary pulmonary hypertension (PPH), mild-to-moderate peripheral airflow obstruction can be found in the majority of patients with this disease. Therefore, ß₂-agonists may affect pulmonary function, blood gases and haemodynamics in patients with PPH.

Pulmonary function testing, blood gas measurements and right heart catheterisation was performed in 22 patients with PPH and the acute effects of inhaled salbutamol (0.2 mg) were measured.

Salbutamol caused an increase in the forced expiratory volume in one second (FEV₁) from 2446±704 to 2550±776 mL. The mean expiratory flow at 50% of the vital capacity (MEF₅₀) rose from 58±17 to 66±21% pred. The pulmonary artery pressures remained unchanged after inhalation of salbutamol, but the cardiac output increased significantly from 3.9±1.4 to 4.2±1.4 L·min^–1 accompanied by significant increases in stroke volume and mixed venous oxygen saturation as well as a significant decrease in pulmonary vascular resistance. The arterial oxygen tension rose from 9±2.4 kPa (68±18 mmHg) at baseline to 9.7±2.8 kPa (73±21 mmHg) after inhalation of salbutamol, the alveolo-arterial oxygen gradient values improved from 6±2.5 kPa (45±19 mmHg) to 5.1±2.9 kPa (38±22 mmHg), respectively.

Inhaled salbutamol has beneficial acute effects on pulmonary function, blood gases and haemodynamics in patients with primary pulmonary hypertension.